A five-year-old boy from Scotland lost his eye after a routine preschool vision test revealed a brain tumour the size of a golf ball. Riley Thompson underwent emergency surgery at Glasgow’s Royal Hospital for Children in February, where doctors diagnosed him with an optic nerve glioma. The tumour was pushing against his eye, leading to the decision to remove the growth, which resulted in the removal of Riley’s eye to save his life. Riley, from Renfrewshire, has since been declared cancer-free and is now engaging in fundraising efforts with his parents, Nicole and Sam, to support research into the illness.
Nicole, a nurse and Riley’s mother, shared her experience, highlighting that despite seeing him daily, she had not noticed any changes in his sight until the eye examination. She urged other parents to be vigilant for any unusual symptoms in their children, emphasising the importance of early detection. Brain Tumour Research reported that brain tumours are the leading cause of cancer-related deaths in individuals under 40, with minimal research funding compared to other cancers. The Thompson family is participating in the 99 Miles in November challenge to raise awareness and funds for brain tumour research.
Following his surgery, Riley faced complications such as a spinal fluid leak but has since started primary school and continued with his hobbies like LEGO and taekwondo. His sister, Isla, has been a supportive sibling throughout Riley’s journey. As they advocate for brain tumour awareness, the family is committed to participating in fundraising initiatives to contribute to finding a cure for all brain tumours. The Thompsons are set to walk 99 miles collectively in November to support the cause and honour Riley’s resilience.
In conclusion, Riley’s story serves as a poignant reminder of the importance of early medical intervention and the strength of families facing challenging medical circumstances. The support and advocacy displayed by the Thompson family underscore the impact of raising awareness and funds for critical research into brain tumours, aiming to improve outcomes for patients like Riley in the future.